Related Experiment Video
Updated: Jan 26, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Systemic lupus erythematosus is a risk factor for atrial fibrillation: a nationwide, population-based study
Sang Yup Lim1, Eun Hui Bae2, Kyung-Do Han3
1Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
Insights
Systemic lupus erythematosus (SLE) significantly increases the risk of developing atrial fibrillation (AF), particularly in younger patients. This increased risk of AF in SLE patients is linked to higher mortality rates, underscoring the need for cardiac monitoring.
Area of Science:
- Cardiology
- Rheumatology
- Epidemiology
Background:
- Cardiac involvement is common in systemic lupus erythematosus (SLE), affecting over half of patients.
- Large-scale data on atrial fibrillation (AF) prevalence in SLE is limited.
- Understanding AF incidence and outcomes in SLE is crucial for patient management.
Purpose of the Study:
- To investigate the incidence of atrial fibrillation (AF) in patients with systemic lupus erythematosus (SLE).
- To assess the clinical significance and mortality associated with AF in SLE patients.
- To identify risk factors for AF development in the SLE population.
Main Methods:
- A retrospective cohort study using the Korean National Health Insurance Service National Sample Cohort (2008-2014).
- Included 21,143 patients with SLE and 105,715 age- and sex-matched controls without prior AF.
- Follow-up until 2015 for AF incidence and mortality.
Main Results:
- The incidence of new-onset AF was significantly higher in SLE patients (2.27%) compared to controls (0.59%).
- SLE was an independent risk factor for AF development (HR, 2.84; 95% CI, 2.50-3.23), especially in patients under 40.
- AF in SLE patients was associated with increased mortality compared to both controls with AF and SLE patients without AF.
Conclusions:
- Systemic lupus erythematosus (SLE) is an independent risk factor for atrial fibrillation (AF) development.
- Younger SLE patients without prior AF are at a higher risk, necessitating cardiac assessment.
- AF development in SLE patients is linked to a significantly increased risk of mortality.
Objectives:
Cardiac involvement is present in more than half of the patients with systemic lupus erythematosus (SLE). However, large-scale studies on the prevalence of atrial fibrillation (AF) in this disease do not exist. We aimed to investigate the incidence and clinical significance of AF in SLE.
Methods:
Patients with SLE (n=21,143; mean age, 41.8±13.13 years; female, 90.38%) without previous AF were selected from the Korean National Health Insurance Service National Sample Cohort database between 2008 and 2014. Age-and sex-matched controls (n=105,715) were randomly sampled in a 5:1 ratio from the population of individuals without SLE from the same database. Both cohorts were followed-up for incidental AF and death until 2015.
Results:
AF was newly detected in 481 (2.27%) patients with SLE and 619 (0.59%) controls (incidence: 3.692 and 0.941 per 1000 person-years, respectively). After multivariate adjustment, SLE was found to be a risk factor for developing AF [hazard ratio (HR), 2.84; 95% confidence interval (CI), 2.50-3.23]. On subgroup analysis, younger (age <40) patients showed a higher incidence of AF. SLE patients with incidental AF had a higher mortality rate compared with patients without SLE with AF (HR, 2.35; 95% CI 1.73-3.20) and those with SLE without AF (HR, 3.53; 95% CI 2.84-4.39) after adjustment.
Conclusions:
SLE was an independent risk factor for AF development, especially in younger patients without previous AF, stressing the importance of cardiac assessment in this population. Development of AF in patients with SLE was associated with increased mortality.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Conservation of Small Populations
Population Growth
What is Population Genetics?

